Recent Acquisition Growth Blue Heron Biotechnology was acquired by Eurofins Genomics in August 2019, positioning it within a larger biotech group with expanded capabilities, which may create cross-selling opportunities for complementary services and joint product offerings.

Market Niche Focus Specializing in gene synthesis within the biotechnology research sector, Blue Heron serves clients requiring advanced genetic fabrication, indicating a target market for laboratory automation, synthetic biology tools, and related biotech solutions.

Revenue Potential With an estimated revenue between 1 million to 10 million dollars, Blue Heron presents a growing company with room for technological enhancement and partnership in equipment, reagents, and software to support their scaling operations.

Technology Engagement The company's tech stack includes digital marketing tools like Google Analytics and AdRoll, indicating an active online presence and potential for digital marketing solutions, targeted advertising, and analytics services to boost their customer acquisition efforts.

Employee and Service Range With a relatively small team of 11 to 50 employees, Blue Heron offers personalized service and could benefit from streamlined laboratory or employee training solutions, as well as innovative biotech partnerships to accelerate their product development.